Claritus Pharmaceuticals Inc. (CLAZF)

[djmurdock]

Take with a grain of salt (stolen from Stock House)

"KALY rumor alert
I have just heard that GW Pharma is in ongoing discussions with Kalytera.

I’ve been told that GW Pharma will look for minority stake in KALY with options in exchange for ongoing guidance as well as capital to advance phase 3 trials.

Options would be exercised upon the successful completion of phase 3 which would give GW a majority stake and overall control.

I imagine this would garner a lot of interest in Kalytera."


Dr. Raphael Mechoulam, Ph.D., is the Co-Chair of the Scientific Advisory Board for Kalytera and also has a relationship with GW Pharma.